We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office

By LabMedica International staff writers
Posted on 30 Mar 2023
Print article
Image: RNA biomarkers may one day help diagnose heart disease (Photo courtesy of Pexels)
Image: RNA biomarkers may one day help diagnose heart disease (Photo courtesy of Pexels)

Doctors may face difficulties in accurately diagnosing whether chest pain or shortness of breath during exercise is due to coronary artery disease (CAD). Common symptoms of heart disease such as chest pain and shortness of breath can be ambiguous and may be caused by other medical conditions such as acid reflux or a pinched nerve. Often, individuals are not aware they have heart disease until they experience a potentially fatal heart attack. Currently, the standard method for diagnosing heart disease is through coronary angiography, which can be done through invasive catheterization or computed tomography. However, 20%-40% of angiograms result in a finding of no blockage. Therefore, doctors and patients may benefit from additional non-invasive and cost-effective diagnostic tools to accurately detect heart disease.

In the largest analysis of blood RNA from patients with angiographically confirmed coronary artery disease (CAD), researchers at the George Washington University (Washington, DC, USA) have demonstrated how RNA biomarkers could be utilized to confirm heart disease. The study has provided new insights into the understanding of heart disease and may potentially lead to the development of a simple blood test that doctors can use to diagnose heart disease right in their office.

The research team used cell type analysis of the differentially expressed genes and found they are related to decreasing abundance or differentiation state of T cells, especially T regulatory cells. The RNA changes are consistent with T cell-related changes in the immune synapse, which may help to define the precise cellular mechanisms of atherosclerotic lesion formation and suggest future optimal diagnostic and therapeutic targets. Combined with other evidence, the results suggest that CAD has an underappreciated component that is likely similar to other autoimmune diseases, such as lupus and psoriasis.

By conducting cell type analysis of the genes that were differentially expressed, the research team discovered a correlation between the decreased abundance or differentiation state of T cells, particularly T regulatory cells. The RNA changes were found to be consistent with T cell-related changes in the immune synapse, which could help to precisely define the cellular mechanisms that lead to the development of atherosclerotic lesions, and identify optimal diagnostic and therapeutic targets in the future. In conjunction with other evidence, these findings suggest that CAD shares a similar underappreciated component with other autoimmune diseases like lupus and psoriasis.

Related Links:
George Washington University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: A false color scanning election micrograph of lung cancer cells grown in culture (Photo courtesy of Anne Weston)

AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell

Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: Fingertip blood sample collection on the Babson Handwarmer (Photo courtesy of Babson Diagnostics)

Unique Hand-Warming Technology Supports High-Quality Fingertip Blood Sample Collection

Warming the hand is an effective way to facilitate blood collection from a fingertip, yet off-the-shelf solutions often do not fulfill laboratory requirements. Now, a unique hand-warming technology has... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.